S. V. Belle

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.

M. Decramer, J. Schellens, J. Schellens, 2001, European journal of cancer.

Mutation analysis of P73 and TP53 in Merkel cell carcinoma

F. Speleman, C. Wolf‐Peeters, R. Sciot, 2000, British Journal of Cancer.

Breast Cancer During Pregnancy: Cases and Review of Treatment and Prognosis

V. Cocquyt, S. Belle, R. Broecke, 2000, Acta clinica Belgica.

Third consensus on medical treatment of metastatic breast cancer.

M. Stockler, M. Gnant, H. Burstein, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY

H Denys, O. de Backer, H. Denys, 2011, Acta clinica Belgica.

Long-term medical costs of postmenopausal breast cancer therapy.

P. Clarys, L. Annemans, V. Cocquyt, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Postmenopausal breast cancer: incidence-based cost of illness

P. Clarys, L. Annemans, V. Cocquyt, 2003 .

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.

P. Blondeel, H. Depypere, V. Cocquyt, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.